Giulia Maria Stella, Valerio Maria Carrozzo, Sara Lettieri, Giulia Alaimo, Enrica Capelletto, Paolo Cameli, Laura Carrozzi, Fabrizio Luppi, Fabio Perrotta
{"title":"Diagnosis and management of interstitial lung disease with concomitant lung cancer in Italy: Results from the ICARO clinician survey.","authors":"Giulia Maria Stella, Valerio Maria Carrozzo, Sara Lettieri, Giulia Alaimo, Enrica Capelletto, Paolo Cameli, Laura Carrozzi, Fabrizio Luppi, Fabio Perrotta","doi":"10.5826/mrm.2026.1072","DOIUrl":"10.5826/mrm.2026.1072","url":null,"abstract":"<p><strong>Background: </strong>Coexistence of interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF), and lung cancer poses major diagnostic and therapeutic challenges, yet clinical management remains heterogeneous. The project aims to describe current Italian practices for integrated management of ILD with concomitant lung cancer. Methods: ICARO (Interstiziopatia e Cancro del polmone: AppRoccio al management clinico integratO) is a national cross-sectional clinician survey conducted in Italy on behalf of the Italian Respiratory Society from November 2024 to March 2025. A 12-item multiple-choice questionnaire assessed diagnostic strategies, treatment preferences, and perceived toxicity risks. Invitations were sent to X physicians, among which 38 ansewered (35 specialists and senior 3 registrars (age range: 28-68 years). Results: An ILD multidisciplinary team was available in 26/38 (71.1%) centres. Diagnostic procedures for lung cancer in ILD patients were reported as performed \"always/often\" by 14/38 (36.8%), with the main concern being ILD progression after procedures (31/38 - 81.6%). Most respondents continued antifibrotic therapy during systemic cancer treatment (28/38- 73.7%). Combined chemotherapy plus immune checkpoint inhibitors was perceived as the highest-risk regimen by 19/38 physicians (50%), and 20/38 (52.6%) were hesitant to offer neoadjuvant immunotherapy in stage II-IIIa NSCLC. Severe toxicity from radiotherapy was reported as frequent by 8/38 (21.1%). Conclusions: Italian clinicians report substantial variability in diagnostic and therapeutic strategies for lung cancer in ILDs, driven mainly by concern for ILD progression and treatment-related pulmonary toxicity. Although limited, this study unveils an urgent need for further prospective studies to better define the safety and efficacy of combined therapeutic approaches and to establish evidence-based guidelines to support clinical decision-making.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1072"},"PeriodicalIF":2.1,"publicationDate":"2026-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13313607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147943550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lushuo Zhang, Mengnan Guo, Hui Wang, Anna Dong, Ning Song, Binghan Zhong, Xiaying Li, Chenqi Liu, Yunxia Zhao
{"title":"Electronic nose technology in bronchial asthma diagnosis and management.","authors":"Lushuo Zhang, Mengnan Guo, Hui Wang, Anna Dong, Ning Song, Binghan Zhong, Xiaying Li, Chenqi Liu, Yunxia Zhao","doi":"10.5826/mrm.2026.1084","DOIUrl":"10.5826/mrm.2026.1084","url":null,"abstract":"<p><p>Electronic nose (e-nose) technology, as an emerging non-invasive diagnostic tool, has demonstrated considerable potential in the diagnosis and management of bronchial asthma. By mimicking the human olfactory system, this technology utilizes gas sensor arrays combined with pattern recognition algorithms to enable rapid analysis and identification of volatile organic compounds (VOCs) in the exhaled breath of patients with asthma. Accumulating evidence suggests that e-nose systems can discriminate between asthma patients and healthy individuals with relatively high accuracy, and they have also shown promising performance in asthma phenotyping. Compared with conventional pulmonary function tests, e-nose technology offers distinct advantages, including cost-effectiveness, rapid response, and non-invasiveness. These features make it particularly suitable for populations requiring repeated dynamic assessment or those unable to perform high-quality pulmonary function testing. However, current evidence is primarily derived from exploratory studies, and heterogeneity exists across studies in terms of population characteristics and methodologies. This highlights the need for further standardized research to improve the consistency and reproducibility of findings.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1084"},"PeriodicalIF":2.1,"publicationDate":"2026-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13313609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147943591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Imaging and AI in tertiary prevention of lung cancer: Narrative review and clinical perspectives.","authors":"Carlo Molfini Curci, Alessandro Morabito, Raffella Pagliaro, Fabio Perrotta, Alessandro Ottaiano, Antonella Santone, Vito D'Agnano, Raffaella Mormile, Adolfo Gallipoli D'Errico, Andrea Bianco, Carmine Picone","doi":"10.5826/mrm.2026.1089","DOIUrl":"10.5826/mrm.2026.1089","url":null,"abstract":"<p><strong>Objective: </strong>To provide a structured narrative review of current evidence and future directions for artificial intelligence (AI) applications in the tertiary prevention of lung cancer, with a focus on radiology-driven recurrence surveillance, treatment response assessment, prognostic stratification, and real-world clinical implementation.</p><p><strong>Methods: </strong>A narrative review was conducted using PubMed, Embase, Web of Science, and IEEE Xplore databases, covering studies published between January 2019 and March 2024. Search terms included lung cancer, tertiary prevention, radiomics, deep learning, recurrence, treatment response, and survival prediction. Studies were selected based on relevance to post-diagnosis clinical management, availability of quantitative performance metrics, and clarity of validation strategy. AI methodologies evaluated included radiomics, convolutional neural networks (CNNs), transformer-based temporal models, ensemble learning, and multimodal data integration. Evidence was critically appraised with respect to study design, cohort size, validation approach, and clinical applicability.</p><p><strong>Results: </strong>Across tertiary-prevention tasks-particularly recurrence detection, treatment response monitoring, and survival prediction-AI-assisted models demonstrate performance improvements over conventional radiological assessment in selected, well-defined scenarios, especially when multimodal imaging and external validation are employed. Reported AUC values for recurrence and response prediction generally range from 0.75 to 0.92, though results remain heterogeneous. Radiomics-deep learning integration and ensemble models show the most consistent gains, while evidence for immunotherapy response prediction and long-term survival modeling remains limited by small cohorts and lack of prospective validation. Key barriers include data heterogeneity, limited interpretability, regulatory constraints, and integration into clinical workflows.</p><p><strong>Conclusions: </strong>AI has the potential to meaningfully support tertiary prevention of lung cancer by enhancing surveillance accuracy, treatment monitoring, and prognostic assessment. However, clinical adoption requires rigorous external validation, standardized imaging and data pipelines, transparent model behavior, and alignment with evolving regulatory frameworks. With continued multidisciplinary collaboration and quality assurance, AI is likely to become an integral adjunct to radiological practice in personalized lung cancer management.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1089"},"PeriodicalIF":2.1,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13313610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heba M Bintalib, Reynie P Raya, Reem Alluhibi, Vruti Dattani, Siobhan O Burns, John R Hurst
{"title":"Utility of the 6-minute walk test and health-related quality of life questionnaires in granulomatous and lymphocytic interstitial lung disease.","authors":"Heba M Bintalib, Reynie P Raya, Reem Alluhibi, Vruti Dattani, Siobhan O Burns, John R Hurst","doi":"10.5826/mrm.2026.1058","DOIUrl":"10.5826/mrm.2026.1058","url":null,"abstract":"<p><strong>Introduction: </strong>Granulomatous lymphocytic interstitial lung disease (GLILD) is a non-infectious complication affecting 10-20% of patients with common variable immunodeficiency disorders. Exercise capacity in GLILD patients, who often report shortness of breath during exercise, has not been previously evaluated. This study aimed to assess the utility of the six-minute walk test (6MWT) as an outcome measure in GLILD. It also evaluated reproducibility and effectiveness of King's Brief ILD Questionnaire (K-BILD) questionnaire in capturing the multidimensional impact of GLILD on quality of life.</p><p><strong>Methods: </strong>This was an observational prospective cohort study. The 6MWT and questionnaires were conducted at baseline and two follow-ups. The 6MWT was performed according to ERS/ATS guidelines. The utility was evaluated by correlating the 6MWT measures (walked distance (6MWD) and distance-saturation product (DSP)) with clinical parameters and health-related quality of life (HRQOL) questionnaires. Reproducibility was assessed using the Intraclass Correlation Coefficient.</p><p><strong>Results: </strong>Thirteen participants (54% male, median age 45 (IQR 38- 62) years) were included. The median 6MWT distance was 457 meters. DSP was the only measure strongly correlated with FVC% and FEV1%, and it showed stronger correlations with clinical measures than 6MWD. The 6MWT has good 6-month and one year reproducibility. Finally, K-BILD appeared to be a useful tool for assessing HRQOL in patients with GLILD, who often have multi-system involvement.</p><p><strong>Conclusion: </strong>Our findings highlight the potential of the 6MWT as a useful measure to assess GLILD. The 6MWT and K-BILD correlations with clinical parameters suggest utility in assessing disease severity and monitoring patients' physical functioning.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1058"},"PeriodicalIF":2.1,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13313608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alina Kabaliei, Vitalina Palchyk, Olga Izmailova, Viktoriya Shynkevych, Oksana Shlykova, Igor Kaidashev
{"title":"The PPAR-gamma agonist pioglitazone alleviates bleomycin-induced lung fibrosis in male BALB/c mice.","authors":"Alina Kabaliei, Vitalina Palchyk, Olga Izmailova, Viktoriya Shynkevych, Oksana Shlykova, Igor Kaidashev","doi":"10.5826/mrm.2026.1068","DOIUrl":"10.5826/mrm.2026.1068","url":null,"abstract":"<p><strong>Background: </strong>Many transcription factors may be involved in the pathogenesis of pulmonary fibrosis (PF). One such factor is PPARG. The PPARG agonist, pioglitazone (PG), has demonstrated general lung protective activity in animal models and is considered a promising therapeutic agent for fibrotic intervention. This study aimed to investigate the effect of PG on the expression of connective tissue remodeling genes in the lungs using bleomycin (BLM)-induced lung fibrosis (BIF).</p><p><strong>Methods: </strong>The study was conducted on male BALB/c mice. PF was induced by pretreatment with bleomycin sulfate and cyclophosphamide. The mice were randomly divided into 3 groups: the first group was administered BLM at a dose of 0.15 U/kg in 50 µl of sterile saline (0.9% NaCl), and the second group was administered 50 µl of saline. The third group was not induced with pulmonary fibrosis and served as a control group. On the 4th day of the experiment, animals from the first and second groups were randomly divided into animals that received PG orally at a dose of 20 mg/kg or saline (40 µl) for 14 days. 4-hydroxyproline was determined in right lung tissue samples. Gene expression was determined using real-time PCR.</p><p><strong>Results: </strong>PG administration to BIF mice resulted in a significant reduction and normalization of the total number of BAL cells, fibrosis score, mRNA expression of genes associated with connective tissue - Col1a1 (P=0.0466), Col3a1 (P=0.0053), Mmp2 (P=0.0006), Tgfb2 (P=0.0459), and Tgfb3 (P=0.0017), as well as mRNA of genes regulating lung connective tissue inflammation and fibrosis - Mrc1 (P=0.0263), Edn1 (P=0.0012), Pparg (P=0.0044), Nr1d1 (P=0.0053) and Fn1 (P=0.0125).</p><p><strong>Conclusions: </strong>PPARG activation by PG alleviates BIF by decreasing collagen deposition, Col1a1 and Col3a1 mRNA expression, remodeling of lung tissue (decreasing Mmp2, Edn1, and Fn1 mRNA), and M2-specific profibrotic macrophage Mrc1 mRNA.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1068"},"PeriodicalIF":2.1,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13313613/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147823243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Phan Sok, Vannary Yi, Virak Sorn, Chendavatey Pok, Sin Chea
{"title":"Clinical characteristics and factors associated with shorter length of hospital stay among deceased COVID-19 patients in Cambodia.","authors":"Phan Sok, Vannary Yi, Virak Sorn, Chendavatey Pok, Sin Chea","doi":"10.5826/mrm.2026.1066","DOIUrl":"10.5826/mrm.2026.1066","url":null,"abstract":"<p><strong>Background: </strong>The length of hospital stay (LoS) among COVID-19 patients is influenced by multiple factors. This study aimed to identify factors associated with LoS among deceased Cambodian patients with confirmed SARS-CoV-2 infection.</p><p><strong>Methods: </strong>We analyzed a total of 106 deceased patients with confirmed SARS-CoV-2 infection reported between March 11 and May 1, 2021, and publicly shared on the Ministry of Health's Facebook page. A zero-inflated Poisson regression model was used to identify factors associated with LoS. Maximum likelihood estimates, and incidence rate ratios (IRRs) were calculated, and model goodness of fit was assessed.</p><p><strong>Results: </strong>The mean LoS to death was 4.39 days (standard deviation, SD = 5.17). Factors associated with a shorter LoS included critical respiratory symptoms (p = .011), being dead on arrival (p < .0001), advanced age (p = .003), residence in a province (p = .004), presence of multiple chronic conditions (p = .0006), and receiving care at a non-designated COVID-19 treatment facility (p = .005). In contrast, each additional day between SARS-CoV-2 diagnosis and hospital admission was associated with an approximately 9% increase in LoS (95% CI 1.07, 1.10).</p><p><strong>Conclusions: </strong>Despite substantial efforts by the Cambodian government to control the pandemic, many COVID-19 patients died shortly after hospital admission. The findings highlight important patient characteristics and underscore the need for improved patient education, strengthened healthcare infrastructure, and enhanced public preparedness for future pandemics.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1066"},"PeriodicalIF":2.1,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gino Soldati, Andrea Smargiassi, Francesco Tursi, Alessandro Zanforlin, Sara Cinquini, Paolo Carlucci, Giampietro Marchetti, Dejan Radovanovic, Riccardo Inchingolo
{"title":"Paradigm shift in medicine and in clinical reasoning method: time has come for a new chest semiotics.","authors":"Gino Soldati, Andrea Smargiassi, Francesco Tursi, Alessandro Zanforlin, Sara Cinquini, Paolo Carlucci, Giampietro Marchetti, Dejan Radovanovic, Riccardo Inchingolo","doi":"10.5826/mrm.2026.1090","DOIUrl":"10.5826/mrm.2026.1090","url":null,"abstract":"<p><strong>Introduction: </strong>Clinical reasoning in medicine is a complex cognitive process that integrates sensory perception, interpretation, and abductive inference to develop diagnostic hypotheses. Despite the rise of artificial intelligence, the patient-clinician encounter remains rooted in semiotics and a probabilistic approach driven by Bayesian updating. In this context, medical knowledge is viewed as context-dependent and subject to continuous revision based on new clinical signs.</p><p><strong>Main body: </strong>This paper identifies bedside ultrasonography as a transformative \"epistemic mediator\" that enhances traditional semiotics by uncovering subtle clinical signs often missed by conventional inspection, palpation, percussion, and auscultation. In managing respiratory diseases, ultrasound provides direct, contextualized data that refines the interpretation of findings such as dullness, altered fremitus, and crackles by linking them to specific anatomical correlates. Based on these principles, the AdET-CHEPHEUS initiative proposes a new paradigm for chest physical examination centered on three pillars: 1) Visual inspection; 2) Auscultation integrated with ultrasound; 3) Palpatory ultrasound evaluation Conclusion: By replacing traditional percussion with more informative and reproducible ultrasound-based methods, this model aligns modern technology with classical clinical epistemology. The integration of ultrasound into bedside reasoning represents a vital evolution in chest semiotics, preserving the human element of the diagnostic process while increasing accuracy.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1090"},"PeriodicalIF":2.1,"publicationDate":"2026-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147596010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Semiotics and clinical reasoning: Thoracic ultrasound as an epistemic mediator.","authors":"Lorenzo Magnani","doi":"10.5826/mrm.2026.1099","DOIUrl":"10.5826/mrm.2026.1099","url":null,"abstract":"","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1099"},"PeriodicalIF":2.1,"publicationDate":"2026-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147596044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Giorgio Lorini, Stefania Ottaviani, Ilaria Giana, Giulia Accordino, Alice Maria Balderacchi, Angelo Guido Corsico, Ilaria Ferrarotti, Davide Piloni
{"title":"Novel mutation (M<sub>angera</sub>-E288V) in alpha-1 antitrypsin deficiency.","authors":"Giorgio Lorini, Stefania Ottaviani, Ilaria Giana, Giulia Accordino, Alice Maria Balderacchi, Angelo Guido Corsico, Ilaria Ferrarotti, Davide Piloni","doi":"10.5826/mrm.2026.1053","DOIUrl":"10.5826/mrm.2026.1053","url":null,"abstract":"<p><strong>Background: </strong>Alpha-1 antitrypsin deficiency is an autosomal, codominant disorder caused by mutations of the SERPINA1 gene. Several mutations have been described associated with the development of pulmonary and/or chronic liver diseases. We report a novel mutation Mangera, identified for the first time in an Italian patient originating from the city of Angera (Varese), Italy.</p><p><strong>Case presentation: </strong>This case report describes a 64-year-old Italian male, a lifelong non-smoker, diagnosed with severe alpha-1 antitrypsin deficiency (AATD) as composed heterozygous with S allele and a novel mutation named Mangera. The patient presented with exertional dyspnea and had reduced serum AAT levels (0.54 g/L). Pulmonary function tests indicated mild airway obstruction with preserved diffusion capacity, and chest CT scans revealed early centrilobular emphysema and fibrotic changes. Genetic analysis was performed, finding a previously unreported mutation. Despite the severe AAT deficiency, the patient exhibited no significant clinical, radiological, or functional deterioration. Given the absence of disease progression, augmentation therapy was deferred in favor of ongoing annual monitoring.</p><p><strong>Conclusions: </strong>This case report highlights the necessity of referring patients to specialized centers equipped with the expertise and tools required for precise diagnosis. Furthermore, the identification of the Mangera mutation expands the spectrum of known SERPINA1 variants associated with severe AATD, emphasizing the ongoing need for vigilance and thorough investigation in cases of suspected deficiency.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1053"},"PeriodicalIF":2.1,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13086044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147367152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Highlights from the Italian National Congress of Imaging in Pulmonology 2025: fostering implementation of advanced technologies for precision patient-centered care.","authors":"Guido Marchi, Michele Mondoni","doi":"10.5826/mrm.2026.1086","DOIUrl":"10.5826/mrm.2026.1086","url":null,"abstract":"<p><p>The Italian National Congress of Imaging in Pulmonology, held in Milan on November 21st, provided a unique educational platform exploring the evolving role of thoracic imaging in respiratory medicine. Organized by the Italian Respiratory Society (SIP-IRS) Imaging Study Group, the congress brought together over 160 participants, including pulmonologists, radiologists, interventional specialists, and early-career professionals, reflecting the essential role of multidisciplinary collaboration in modern respiratory care. Topics included functional imaging approaches to small airway disease in COPD and asthma, multimodal imaging in lung transplantation, the role of CT angiography for haemoptysis management, and radiomics applications for quantifying emphysema patterns and fibrotic changes. The role of imaging in guiding inhaled and biological therapies was explored, alongside a lively debate on thoracic ultrasound for interstitial lung disease screening. Advanced sessions covered medical thoracoscopy techniques, quantitative ultrasound and artificial intelligence in pleural diseases, shape-sensing robotic-assisted bronchoscopy for peripheral nodules, expanding cryobiopsy applications, and imaging's role in monitoring progressive pulmonary fibrosis therapeutics. A distinctive feature was the first \"Images in Pulmonology\" contest, won by a remarkable case simultaneously depicting lung cancer and new life. This meeting report summarizes key congress highlights and underscores the importance of fostering multidisciplinary collaboration and structured imaging education to bridge the gap between technological capabilities and clinical expertise in respiratory medicine.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1086"},"PeriodicalIF":2.1,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13086045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147357585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}